GeneDx Holdings Corp.
WGS- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001818331
In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 223 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding GeneDx Holdings Corp. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 58 | 53 | −5 |
| Shares | 14.1M | 13.9M | −112.4K (−0.8%) |
| Value | $83.8M | $50.8M | −$33.0M (−39.4%) |
New holders (5)
Institutions that held GeneDx Holdings Corp. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 28,000 | $101.9K | 0.00% |
| Tower Research Capital LLC (TRC) | 10,086 | $36.7K | 0.00% |
| Thompson Davis & Co., Inc. | 10,000 | $36.4K | 0.05% |
| Qube Research & Technologies Ltd | 1,939 | $7.06K | 0.00% |
| UBS Group AG | 192 | $699 | 0.00% |
Sold out (10)
Institutions that held GeneDx Holdings Corp. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 225,693 | $1.35M |
| Charles Schwab Investment Management Inc | 95,189 | $567.3K |
| AQR Capital Management LLC | 19,438 | $115.8K |
| Y-Intercept (Hong Kong) Ltd | 14,839 | $88.4K |
| Jump Financial, LLC | 14,832 | $88.4K |
| Two Sigma Investments, LP | 12,551 | $74.8K |
| Victory Capital Management Inc | 11,617 | $69.2K |
| New York State Common Retirement Fund | 71 | $420 |
| Pittenger & Anderson Inc | 4 | $24 |
| Deutsche Bank AG | 1 | $6 |